FDA Acts To Speed Bioterror Medicines

FDA Acts To Speed Bioterror Medicines
Responding to the threat of anthrax and other forms of chemical and biological terrorism, the Food and Drug Administration adopted new rules yesterday that will speed the approval of drugs that could protect people from attacks.

Comments are closed.